Retrospective review of diphencyprone in the treatment of alopecia areata [PDF]
, 2015 Contact immunotherapy with diphencyprone (DCP) is used to treat alopecia areata (AA). Its reported efficacy is variable, and individual response cannot be predicted.
Holmes, S., Lamb, R. C., Young, D.
core +1 more source
Siriraj Medical Journal, 2017 Background: Alopecia totalis (AT) and alopecia universalis (AU) have a high rate of recurrence and are very difficult to treat. To date, no consensus has been reach among clinicians regarding the best way to treat these conditions.
Rattapon Thuangtong
doaj +3 more sources
Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1
Case Reports in Endocrinology, 2021 Autoimmune polyglandular syndrome type 1 (APS1) is a progressive life-threatening illness with no known cure. Current treatments involve replacement of the hormone deficiencies that result from autoimmune destruction of multiple endocrine organs.
Jill D. Jacobson +3 more
doaj +1 more source
Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies [PDF]
, 2016 Scalp psoriasis with alopecia is a rare cutaneous reaction to tumor necrosis factor alpha antagonists. This reaction often reverses with discontinuation of the offending drug and initiation of topical treatments; however, irreversible hair loss may occur
Jeremy Udkoff, Philip R. Cohen
core +1 more source
Chromosomal assignment of the ovine hairless (hr) gene by fluorescence in situ hybridization. [PDF]
, 2008 Congenital hypotrichosis in mammalian species consists of partial or complete absence of a hair coat at birth. Affected individuals having a partial hair coat at birth may loose it subsequently.The aim of this paper was to physically map the ovine hr
Budelli E +6 more
core +1 more source
Alopecia areata – Current understanding and management [PDF]
, 2022 Alopecia areata (AA) is a chronic, immune-mediated disease characterized by acute or chronic non-scarring hair loss, with a heterogeneity in clinical manifestations ranging from patchy hair loss to complete scalp and body hair loss. An overview of the up-
Blume‐Peytavi, Ulrike +5 more
core +1 more source
New Modalities in the Treatment of Refractory Alopecia Areata [PDF]
, 2017 Alopecia areata (AA) is a common and complex T-cell–mediated inflammatory disorder. It may be patchy (localized), involve the entire scalp (alopecia totalis) or entire body (alopecia universalis).
Kılıç, Arzu
core +2 more sources
Treatment of alopecia totalis/universalis/focalis with vitamin D and analogs: Three case reports and a literature review [PDF]
, 2021 BACKGROUND: Alopecia areata (AA) is an inflammatory disease with autoimmune, environmental, and inherited components directed at the hair follicle, either limited to patchy hair loss over the scalp (Focalis, AF), total loss of scalp hair (Totalis, AT ...
Alexopoulos, Alexios +4 more
core +1 more source
Drug Reaction with eosinophilia and systemic symptoms with alopecia universalis and vitiligo
Medicina, 2021 Drug reactions with eosinophilia and systemic symptoms (DRESS) are rare and potentially fatal adverse hypersensitivity reaction to some drugs, especially anticonvulsants. The syndrome affects not only the skin but also other organs, especially the liver.
Ives Alexandre Yutani Koseki +5 more
doaj
Computer-guided concentration-controlled trials in autoimmune disorders [PDF]
, 1993 A randomized concentration-controlled clinical trial (RCCCT) is an alternate experimental design to the standard dose-controlled study. In a RCCCT, patients are randomly assigned to predefined plasma or blood drug concentration ranges (low, medium, and ...
Doyle, H +7 more
core +1 more source